BANGKOK, May 27, 2026 - (ACN Newswire via SeaPRwire.com) - Sappe Public Company Limited (SAPPE), a leading innovator in beverages from Thailand and the creator of the global “Snack Drink” category, continues to energize the international market with the launch of its latest global campaign for “Mogu Mogu” under the concept “Wanna Skip? You Gotta Chew.” The campaign invites Generation Z worldwide to keep going through life’s unskippable moments simply by drinking and chewing “Mogu Mogu,” transforming everyday challenges into enjoyable and manageable experiences while reinforcing the brand’s position as a global snackable drink that brings fun into every moment.As a fruit juice with nata de coco beverage that has pioneered a unique category and achieved market leadership in several countries, including the Philippines, South Korea, and the United Kingdom (based on NIQ data), “Mogu Mogu” continues to differentiate itself through its signature “Tangible Fun” experience, combining refreshing fruit flavors with its iconic chewy coconut jelly. Beyond enjoyment, the act of chewing is also associated with a sense of relaxation, making it a natural companion for moments that feel beyond control. The campaign builds on a key insight into Generation Z, who have grown up in a digital world where they can easily skip unwanted content, yet cannot skip real-life situations. “Mogu Mogu” steps in as a simple yet meaningful solution, helping them navigate those moments in their own way through a playful and sensory drinking experience.Ms. Piyajit Ruckariyapong, Chief Executive Officer of Sappe Public Company Limited, said, “Generation Z is a powerful force shaping global trends. They value experiences, fun, and authenticity. The ‘Wanna Skip? You Gotta Chew’ campaign reflects our deep understanding of their behavior. ‘Mogu Mogu’ is not just a beverage; it is an experience that helps consumers navigate everyday moments in a fun and natural way. This aligns with our ambition to grow a Thai brand into a truly global brand that resonates with consumers across diverse markets.”The campaign adopts a 360-degree strategy across both online and offline channels. Digitally, it leverages full-scale social media engagement and influencer collaborations in each market to drive awareness and participation. On-ground, the brand activates sampling and immersive brand experiences across key markets, including the Philippines, South Korea and the United Kingdom, bringing consumers closer to the brand and reinforcing emotional connections. This global rollout reflects SAPPE’s vision to elevate “Mogu Mogu” beyond refreshment into a “moment of tangible fun” that fits seamlessly into everyday life.“Mogu Mogu” is one of SAPPE’s flagship brands and a pioneer of the “Snack Drink” category, being the world’s first fruit juice beverage with nata de coco. Today, the brand is available in over 100 countries worldwide, known for its wide variety of flavors and distinctive chewy texture that sets it apart. With its strong global presence and continuous innovation, “Mogu Mogu” continues to win the hearts of consumers and strengthen its position as a fast-growing global brand. For more information and updates, follow “Mogu Mogu” on TikTok and Instagram, or visit www.mogumogu.com.About SAPPESappe PCL (SAPPE) is a leading Thai beverage innovator and the creator of the "Snack Drink" category through its iconic global brand, Mogu Mogu, now exported to over 100 countries across Asia, Europe, the Middle East, and beyond. The company specializes in fruit juice and functional health beverages designed to serve the evolving lifestyle needs of modern consumers around the world.SAPPE's diverse portfolio includes globally recognized brands such as Mogu Mogu, the world's first snackable drink; Sappe Aloe Vera, known for its refreshing taste and natural ingredients; and Sappe Beauti, a functional drink line focused on health, wellness, and women empowerment. Headquartered in Bangkok, Thailand, SAPPE is listed on the Stock Exchange of Thailand (SET) under the symbol SAPPE.Driven by innovation, deep consumer insights, and a strong commitment to sustainability, SAPPE operates with a balanced focus on product innovation, economic performance, social responsibility, and environmental impact. The company believes that building a sustainable future begins with valuing people, embracing diversity, and leading with authenticity, creativity, and the courage to drive positive change. SAPPE's mission is to inspire lives worldwide one meaningful beverage at a time.Sappe official: https://www.sappe.com/en/Facebook: https://www.facebook.com/sappeplaygroundInstagram: https://www.instagram.com/mogumogu_global/Line: https://shop.line.me/@sappeonlineShopee: https://shopee.co.th/sappe.officialEmail: corpcom@sappe.comSappe PCL [SET: SAPPE, SAPPE/F, SAPPE-R] https://www.sappe.com/en/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
About: acn
Posts by acn:
‘European Dairy from Ireland’ Responds to Growing Demand for Functional Nutrition
SINGAPORE, May 27, 2026 - (ACN Newswire via SeaPRwire.com) - The European Union is strengthening its engagement with Singapore as a regional hub for advanced food manufacturing and nutrition innovation. This comes as demand for functional dairy ingredients accelerates across Southeast Asia. Led by Bord Bia – The Irish Food Board, the initiative is part of the “European Dairy: Ireland, Where Nature Meets Science” campaign, a €3.2 million investment co-funded by the European Union to strengthen Asia’s nutrition pipeline and foster long-term trade partnerships. The campaign showcases sustainable farming and scientific research behind European dairy production. Singapore is a Strategic Gateway for Functional Nutrition in AsiaSingapore is globally recognised as a hub for innovation, positioned at the heart of Southeast Asia’s food ecosystem, and has an important role in regional product development and distribution. Manufacturers across ASEAN are increasingly seeking high-quality science-backed ingredients, as demand for targeted life-stage nutrition, preventative health products and functional foods is increasing. This is largely driven by the fact that Southeast Asia’s population is growing and aging rapidly, particularly in Singapore, leading to increased demand for functional foods to support healthy aging and overall wellbeing. Given limited domestic dairy production in Singapore, F&B innovators and manufacturers are driven to rely on imports and seek trusted international partners.Ms. Lorna Allen, South East Market Manager of Bord Bia, mentioned, “Singapore is a key gateway for European dairy engagement in Southeast Asia, particularly as demand for functional and science-backed nutrition continues to grow. Ireland has exported €276 million value of dairy products to Southeast Asia in 2025, a y-o-y increase of 16.4%. Through the EU-funded campaign, Bord Bia is supporting closer collaboration between European dairy producers from Ireland and regional food and nutrition innovators.”Dr Kalpana Bhaskaran, Deputy Director, industry partnerships and Head, Glycemic Index Research Unit at Temasek Polytechnic, commented, “Dairy ingredients play a vital role across the life course. With protein‑fortified and functional dairy products gaining strong momentum, the opportunity to improve population health through evidence‑based dairy innovation has never been greater.”A Science-Led Advantage Supporting Industry Needs European dairy from Ireland combines a natural grass-fed, pasture-based system with the support of advanced scientific research. This combination of natural production methods and scientific validation allows European dairy to meet the performance and quality requirements of manufacturers across Asia.Dr. André Brodkorb, Senior Researcher, Teagasc Food Research Centre Moorepark, said, “Irish grass‑fed milk is scientifically proven to deliver superior nutritional benefits, with Teagasc research showing dairy cows who operate on an Irish grass-fed system, produced milk with higher percentages of omega-3 and conjugated linoleic (CLA) fatty acids compared to cows fed medium and low proportions of grass.”European Dairy Powders at FHA Singapore 2026Bord Bia brought leading European dairy suppliers from Ireland to Food & Hospitality Asia (FHA) in Singapore last April. Industry professionals attending FHA Singapore were invited to explore partnership opportunities and discover how European dairy from Ireland is supporting the next generation of nutrition solutions in Asia. Bord Bia focused on: Functional dairy ingredients designed for sports nutrition, healthy ageing, life-stage nutrition, and foodservice.Solutions that support product innovation for Asian consumers.Opportunities to connect directly with suppliers for sourcing and collaboration.Strengthening Collaboration Across the RegionAs part of the European Union’s engagement in Singapore, Bord Bia is also facilitating a closed-door industry session bringing together stakeholders from research, development, and manufacturing. This reflects ongoing collaboration between European dairy stakeholders and regional partners, including organisations such as Temasek and Teagasc, to support innovation and knowledge exchange in functional nutrition. More information about the campaign is available at: https://european-dairy.eu/Media Contact:Wani DiwarkarE: wani@prbespoke.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
New Tech, Greener Future: Sinoma International Green and Intelligence Innovation Exchange Held in Chengdu
CHENGDU, CHINA, May 27, 2026 - (ACN Newswire via SeaPRwire.com) - The Sinoma International Green and Intelligence Innovation Exchange, themed "Green Intelligence Empowers Cooperation" opened in Chengdu, Sichuan Province on May 19, 2026.The event was attended by diplomatic envoys from Zambia, Zimbabwe, Ghana, Côte d'Ivoire, Nigeria, Syria and other countries, representatives of industrial associations worldwide, academicians from the Chinese Academy of Engineering and the Royal Academy of Engineering, as well as officials from global organizations including the Global Cement and Concrete Association and World Cement Association.Zhou Yuxian, Chairman of China National Building Material Group (CNBM), stated in his speech that cement is evolving from a traditional industrial product into a high-performance, low-carbon and eco-friendly material. The company stands ready to work with global peers to reshape industrial value and build a more resilient cement industry ecosystem.Officials with Sichuan Provincial Department of Commerce and Department of Science and Technology introduced local policies to advance high-end, intelligent and green transformation of the building materials sector, inviting global investors to seek cooperation in Sichuan.Ambassadors of Zimbabwe and Ghana to China spoke highly of Sinoma International’s achievements in cement manufacturing and infrastructure construction in their respective countries, voicing expectations for deeper practical cooperation across diverse fields.Four major innovative achievements of 2026 in the industry were unveiled at the forum: full-industrial chain treatment solutions for waste-free cities, ultra-low emission system for industrial flue gas, full-process intelligent open-pit mine solution and intelligent operation and maintenance system solution.Three academicians of the Chinese Academy of Engineering Miao Changwen, Liu Jiaping, Peng Shou, and Karen Scrivener from the Royal Academy of Engineering delivered keynote speeches, sharing cutting-edge insights on cement-based new energy materials, aluminosilicate cementitious systems, advanced building material upgrading and sustainable construction.Four themed sub-forums were arranged covering green and low-carbon, mining development, digital intelligence and green energy and environmental protection. Guests also paid field visits to a circular economy industrial park, an intelligent mine and a prefabricated construction base.During the conference, senior executives of CNBM met with diplomatic envoys and held talks with cement association representatives from Germany, Iraq, Vietnam, Brazil and Russia. Client delegates from 12 international building material enterprises including Heidelberg Materials, TITAN Group and YTL Group joined strategic communication sessions.Yin Zhisong, Chairman of Sinoma International, remarked that technological innovation serves humanity and protects the planet. Boasting over seven decades of technological expertise and a global operational network, Sinoma International is willing to share technologies, set industrial standards and jointly pursue sustainable development with global partners.Company: SINOMA International Engineering Co., LtdContact Person: Deng JiexiEmail: dengjiexi@sinoma.com.cn Website: http://www.sinoma.com.cn/Telephone: (010) 64399322City: Beijing Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Digital China Holdings Wins Capital Market Approval for Its ‘Data x AI’ Strategy
HONG KONG, May 27, 2026 - (ACN Newswire via SeaPRwire.com) - Recently, Digital China Holdings Limited (861.HK) has successively garnered significant recognitions from the capital market. This marks the increasing clarity of the company's "Data x AI" strategic roadmap and demonstrates the capital market's strong confidence and high expectations for its future development.At the "8th GOLDEN KUNPENG CHINA FINANCIAL VALUE RANKING" awards ceremony, hosted by the Hong Kong Commercial Daily in Hong Kong on May 26, the company won two major accolades: "Best CFO of a Listed Company - Zhang Yunfei" and "Listed Company with the Greatest Value Growth Potential." Upholding the principles of "openness, fairness, and justice," the "Golden Kunpeng" China Financial Value Rankings are dedicated to building an authoritative, professional, credible, and influential evaluation platform and brand content for listed companies in the Chinese capital market. Furthermore, a number of mainstream domestic and international brokerages—including Guotai Haitong Securities, CSC Financial, ICBC International, Global Wealth, Zhongtai Securities, Great Wall Securities, and China Post Securities—have released their 2025 earnings review reports of the company, initiating "Buy" and "Overweight" ratings. The market unanimously favors the company's earnings inflection point and the strategic value of its AI initiatives.On March 30, Digital China Holdings announced its full-year results for 2025, delivering an impressive performance by turning losses into profits. The company's annual operating revenue reached RMB 21.02 billion, representing a year-on-year increase of 26%. Non-IFRS adjusted net profit swung from a loss to a profit of RMB 215 million, while net profit attributable to the parent company turned from a loss to a profit of RMB 31.42 million. Net cash flow from operating activities stood at RMB 490 million, with cash on hand amounting to RMB 3.49 billion. The value of newly signed contracts reached RMB 16.19 billion, indicating abundant orders on hand. This high-quality growth is a direct manifestation of the company's "Data x AI" strategy transitioning from a concept to tangible business implementation.Building upon the technological foundation that won the First Prize of the State Technological Invention Award, the company achieved a leapfrog upgrade of its YanYun technology system. It released the YanYun 2.0 Infinity Data Intelligent Decision Enabling Platform and pioneered the "AI First FDE" business model. This enables the deep integration of AI technology with customer business processes, boosting overall operational efficiency by 30 to 50 times and accelerating the project delivery cycle by 5 to 7 times.On May 20, the company officially launched a new-generation AI digital asset management system—the Shenzhou Zhiliao Smart Management Platform. Centered on a "Cloud-Native Architecture + AI Agents," the platform directly addresses the pain points of traditional asset management and establishes a closed-loop system for full-lifecycle asset management. Equipped with an asset management AI agent and a maintenance expert AI agent, the system enables 7x24 fault diagnosis, automatic generation of maintenance plans, and intelligent spare parts matching. Implementation data reveals a 40% reduction in maintenance time, a 20% drop in secondary on-site visits, and a 50% decrease in spare parts mismatch rates. The platform has been efficiently deployed across various industry scenarios, including Tsinghua University, Qin Cloud Infrastructure, and Tai'an City Construction Investment. Concurrently, the company established the Omni-Domain AI Ecosystem Alliance to continuously expand the boundaries of AI applications.In terms of the company's highly advantageous supply chain scenarios, relying on its data intelligence technology base, the self-developed "Little King" intelligent agent cluster has reconstructed the OWTB execution system and the supply chain control tower. The company rolled out applications such as intelligent Q&A, decision-making assistants, and AI-native workstations. These achievements were successfully selected as excellent practice cases for AI industry empowerment at the Economic Observer Tech Innovation Summit, setting an "AI + Supply Chain" benchmark for the industry.From technological breakthroughs and product innovations to a successful earnings turnaround and award recognitions, these milestones signify that Digital China Holdings' "Data x AI" strategy has fully blossomed. Looking ahead, the company will accelerate the deep integration of AI technology across multiple scenarios, accumulate platform experience data, and inject robust momentum into the digital and intelligent transformation of enterprises, as well as the high-quality development of the industry. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
神州控股「Data x AI」戰略路徑獲資本市場認可
香港, 2026年5月27日 - (亞太商訊 via SeaPRwire.com) - 近期,神州控股(861.HK)接連獲得資本市場的重磅認可,標誌著公司「Data x AI」戰略路徑愈發清晰,資本市場對公司的未來發展前景充滿信心與期待。《香港商報》於5月26日在香港舉辦「第八屆全球商報經濟論壇暨金鯤鵬中國財經價值」頒獎典禮,公司斬獲「最佳上市公司CFO——張雲飛」和「最具價值成長潛力上市公司」兩項大獎。「金鯤鵬」 中國財經價值榜評選秉承「公開、公平、公正」的宗旨,致力於打造中國資本市場權威、專業、具有公信力和影響力的上市公司評選平台及品牌內容。此外,國泰海通證券、中信建投證券、工銀國際證券、環球富盛、中泰證券、長城證券、中郵證券等境內外多家主流券商已發布2025年業績點評報告,給予公司「買入」和「增持」評級,一致看好公司業績拐點與 AI 戰略價值。3月30日,神州控股發布2025年全年業績,交出扭虧為盈的業績反轉答卷。公司全年營業收入達人民幣210.15 億元,同比增長26%;Non-IFRS經調整利潤淨額由虧損至人民幣2.15億元,歸母淨利潤由虧損轉為盈利人民幣3,142萬元,經營活動現金淨額人民幣4.90億元,在手現金人民幣34.88億元,新簽約規模人民幣161.90億元,在手訂單充足。此次高質量增長,是公司「Data x AI」戰略從理念落地業務的直接體現。依托國家技術發明獎一等獎成果底座,公司完成燕雲技術體系跨越式升級,發布燕雲2.0 Infinity數據智能決策使能平台,並首創「AI First FDE」業務模式,實現AI技術與客戶業務流程深度耦合,整體運營效率可提升30-50倍,項目交付週期提速5-7倍。5月20日,公司正式發布新一代AI數智化資產管理系統——神州知了智管平台,以「雲原生架構 + AI 智能體」為核心,直擊傳統資產管理痛點,打通資產全生命週期管理閉環,搭載資產管理 AI 智能體與維修專家 AI 智能體,實現 7×24 小時故障診斷、自動生成維修方案、備件智能匹配,落地數據顯示維修時長縮短 40%、上門二次率降低 20%、備件錯配率降低 50%,已在清華大學、秦雲基礎、泰安城投等多個行業場景實現高效落地,公司同步成立智啟千域生態聯盟,拓展 AI 應用邊界。在公司優勢的供應鏈場景方面,依托數據智能技術底座,自研 「小金」 智能體集群重構 OWTB 執行系統和供應鏈控制塔,推出智能問答、決策助手、AI 原生工作台等應用,成功入選《經濟觀察報》科技創新峰會人工智慧行業產業賦能實踐優秀案例,樹立「AI+供應鏈」行業標桿。從技術突破、產品創新到業績反轉、獎項認可加冕,標誌著神州控股 「Data x AI」 戰略全面落地生花。未來,公司將加速 AI 技術與多場景深度融合,沉澱平台經驗數據,為企業數智化轉型與行業高質量發展注入強勁動力。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Adyton Successfully Achieves Major Mining Advancement Milestone at The Wapolu Gold Project
BRISBANE, AUS, May 26, 2026 - (ACN Newswire via SeaPRwire.com) - Adyton Resources Corporation (TSXV: ADY) ("Adyton" or the "Company") is pleased to announce the successful completion of the Mining Lease Warden's Hearing for the recommencement of mining operations at the historic Wapolu Gold Mine ("Wapolu" or the "Project") on Fergusson Island, Papua New Guinea. The Hearing, held on May 21, 2026, represents a significant milestone in the Mining Lease application process and an important step toward advancing Wapolu toward potential redevelopment and future production.Conducted by senior Mineral Resources Authority ("MRA") Mining Warden Mr. Kopi Wapa at the Wapolu exploration camp, the Hearing forms a mandatory component of the Mining lease approval process and is intended to formally assess community support for the granting of a mining lease to the project developer. The Hearing was attended by all principal landowners, alongside key representatives from Adyton, its joint venture partner, East Vision Investment Holdings ("EVIH") and the Provincial Government, underscoring the strong engagement and collaborative approach being taken as the Company advances the Project. The Warden will now submit a report on the hearing to the Mineral Resources Authority Mining Advisory Council (MAC) following which the MAC will complete its assessment for the grant of the Mining Lease.Exploration Licence EL 2549, which hosts the Wapolu Gold Project, is currently the subject of a Mining Lease application ML 1390 and Lease For Mining Purposes, LMP 152. Together, these statutory permits are intended to support the recommencement of mining operations at the historic Wapolu mine. The Mining Lease application covers the proposed mining and processing operations while the LMP application relates to supporting non-processing infrastructure including such facilities as airstrips.The Wapolu Project, together with the neighboring Gameta license area, represents two of the most advanced development assets on Fergusson Island. Both projects are being actively advanced through the permitting and development process by Adyton and EVIH."The successful completion of the Warden's Hearing marks another major milestone in advancing Wapolu toward the potential recommencement of mining operations. In Papua New Guinea, the Warden's Hearing is a critical and mandatory component of the regulatory process, providing local stakeholder and landowners with the opportunity to formally participate in the transition from exploration to mining," said Tim Crossley, CEO of Adyton. "We are extremely encouraged by the strong support demonstrated by land holder, community representatives and other stakeholders throughout the Hearing process. Their support reflects the collaborative relationships Adyton and EVIH have built on Fergusson Island and reinforces the significant opportunity we see in advancing Wapolu and the broader Fergusson Island projects toward development."Louis Wang, Project Director of EVIH, commented, "We are very pleased with the show of support by the Wapolu community for the re-start of mining at Wapolu. This community from day 1 of EVIH commencing exploration work at Wapolu has been a pleasure to work with and always shown strong support for our activities. We now look forward to working with the community as we transition the project back into a full-scale mining, processing and concentrate export operation." Mining Warden Kopi Wapa addresses local Wapolu LandownersTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7416/298733_c560c22e942a18ba_001full.jpgMining Warden Kopi Wapa, Clifford Pakailasi from the Provincial Government, Adyton and EVIH representatives Tom Charlton, Louis Wang and Gary Wang along with community representatives following the completion of the warden hearing formalitiesTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7416/298733_c560c22e942a18ba_002full.jpgFor further information please contact:Tim Crossley, Chief Executive Officer E‐mail: tcrossley@adytonresources.comPhone: +61 7 3854 2389Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.ABOUT ADYTON RESOURCES CORPORATIONAdyton Resources Corporation is focused on advancing gold and copper projects in world-class mineral jurisdictions. The Company holds a portfolio of highly prospective assets in Papua New Guinea where it is actively working to expand its existing gold Inferred and Indicated Mineral Resources and build on recent high-grade gold and copper drill results at its 100% owned Feni Island project.Adyton's projects are located on the Pacific Ring of Fire, on accessible island settings that host several globally significant deposits including the Lihir gold mine and Panguna copper-gold mine on Bougainville Island, both in close proximity to Feni, highlighting the district-scale potential of the Company's land package.Feni Island Au-Cu projectThe Feni Island Project currently has a mineral resource prepared in accordance with NI 43-101 dated October 14, 2021, which has outlined an initial inferred mineral resource of 60.4 million tonnes at an average grade of 0.75 g/t Au, for contained gold of 1,460,000 ounces, assuming a cut-off grade of 0.5 g/t Au. See the NI 43-101 technical report entitled "NI 43-101 Technical Report on the Feni Gold-Copper Property, New Ireland Province, Papua New Guinea prepared for Adyton Resources by Mark Berry (MAIG), Simon Tear (MIGI PGeo), Matthew White (MAIG) and Andy Thomas (MAIG), each an independent mining consultant and "qualified person" as defined in NI 43-101, available under Adyton's profile on SEDAR+ at www.sedarplus.ca. Mineral resources are not mineral reserves and have not demonstrated economic viability.Fergusson Island Au projectsThe Fergusson Island Projects currently have a mineral resource prepared in accordance with NI 43-101, which outlined an indicated mineral resource of 5.0 million tonnes at an average grade of 1.28 g/t Au for contained gold of 206,000 ounces and an inferred mineral resource of 23.2 million tonnes at an average grade of 0.99 g/t Au for contained gold of 733,000 ounces, both inferred and indicated resources used a 0.5g/t Au cut-off grade, refer Table below for a breakdown of the Fergusson Island projects Mineral Resources.ProjectIndicatedInferredAu(g/t)Tonnes(million)Au(koz)Au(g/t)Tonnes(million)Au(koz)Gameta exploration licence1.334.01731.0110.5340Wapolu exploration licence1.001.0330.9712.7393Fergusson Island Gold Project1.285.02060.9923.2733 Gameta and Wapolu resources at 0.5g/t gold cut-off See the technical report dated October 14, 2021, entitled "NI 43-101 Technical Report on the Fergusson Gold Property, Milne Bay Province, Papua New Guinea" prepared for Adyton Resources by Mark Berry (MAIG), Simon Tear (MIGI PGeo), Matthew White (MAIG) and Andy Thomas (MAIG), each an independent mining consultant and "qualified person" as defined in NI 43-101, available under the Company's profile on SEDAR+ at www.sedarplus.ca. Mineral resources are not mineral reserves and have not demonstrated economic viability.See the technical report dated January 7, 2026, entitled "NI 43-101 Technical Report on Wapolu Gold Project" prepared for Adyton Resources by Louis Cohalan (MAIG), an independent mining consultant and "qualified person" as defined in NI 43-101, available under the Company's profile on SEDAR+ at www.sedarplus.ca. Mineral resources are not mineral reserves and have not demonstrated economic viability.For more information about Adyton and its projects, visit www.adytonresources.com.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7416/298733_c560c22e942a18ba_003full.jpgForward-looking statementsThis press release includes "forward‐looking statements", including forecasts, estimates, expectations, and objectives for future operations that are subject to several assumptions, risks, and uncertainties, many of which are beyond the control of Adyton. Forward‐looking statements and information can generally be identified by the use of forward‐looking terminology such as "may", "will", "should", "expect", "intend", "estimate", "anticipate", "believe", "continue", "plans" or similar terminology. Forward-looking statements in this news release include plans pertaining to the drill program, the intention to prepare additional technical studies, the timing of the drill program, uses of the recent drone survey data, the timing of updating key findings, the preparation of resource estimates, and the deeper exploration of high-grade gold and copper feeder systems. The forward‐looking information contained herein is provided for the purpose of assisting readers in understanding management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes.Forward‐looking information are based on management of the parties' reasonable assumptions, estimates, expectations, analyses, and opinions, which are based on such management's experience and perception of trends, current conditions and expected developments, the receipt of any necessary permits, licenses and regulatory approvals in connection with the future development of the projects in a timely manner; the availability of financing on suitable terms for the development; construction and continued operation of the Fergusson Island Project and the Feni Island Project; the ability to effectively complete the drilling program; and Adyton's ability to comply with all applicable regulations and laws, including environmental, health and safety laws.Investors are cautioned that forward-looking statements are not based on historical facts but instead reflect Adyton's management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of managements considered reasonable at the date the statements are made. Although Adyton believes that the expectations reflected in such forward-looking statements are reasonable, such information involves risks and uncertainties, and under reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements expressed or implied by Adyton. Among the key risk factors that could cause actual results to differ materially from those projected in the forward-looking statements are the following: impacts arising from the global disruption, changes in general macroeconomic conditions; reliance on key personnel; reliance on Zenex Drilling; changes in securities markets; changes in the price of gold or certain other commodities; change in national and local government, legislation, taxation, controls, regulations and political or economic developments; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected formations pressures, cave‐ins and flooding); discrepancies between actual and estimated metallurgical recoveries; inability to obtain adequate insurance to cover risks and hazards; the presence of laws and regulations that may impose restrictions on mining; employee relations; relationships with and claims by local communities and indigenous populations; availability of and changes in the costs associated with mining inputs and labour; the speculative nature of mineral exploration and development (including the risks of obtaining necessary licenses, permits and approvals from government authorities); and title to properties. Investors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially from those projected in the forward‐looking statements. Such forward‐looking information represents management's best judgment based on information currently available. No forward‐looking statement can be guaranteed, and actual future results may vary materially. Readers are cautioned not to place undue reliance on forward-looking statements or information. Adyton Resources Corporation undertakes no obligation to update forward‐looking information except as required by applicable law.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298733 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
澤景股份披露上市後的首份年報:業績高增技術壁壘深厚 未來成長潛力十足
香港, 2026年5月26日 - (亞太商訊 via SeaPRwire.com) - 近期,澤景股份(2632.HK)發佈公司登陸港股首份年度成績單,作為國內車載HUD解決方案頭部企業,這份年報完整勾勒出公司營收高增、技術深耕、產品迭代、賽道卡位的發展全貌,中長期核心投資價值充分釋放。從經營基本面來看,澤景股份2025年營收穩步攀升至6.67億元,近三年營收複合增長率突破30%,在智能汽車行業週期波動中展現出極強的增長韌性。研發端公司始終堅持技術立企,全年研發費用同比增幅達9.1%,持續加碼光學設計、機械工程、電子設計、軟件算法、AR成像及人機交互HMI等核心底層技術研發,依託全流程自研技術架構築牢深厚技術護城河,鞏固行業差異化競爭優勢。產品結構優化成為公司最大亮點,高附加值AR-HUD業務迎來爆發式增長,高附加值AR-HUD業務收入快速攀升,AR-HUD(CyberVision)銷量同比增長226.6%,占比從8.6%提升至21%,標誌著公司正式完成從傳統HUD向高階AR-HUD的戰略躍遷,高端化轉型成效凸顯,徹底擺脫行業低端價格內卷泥潭。業績高增雙重賦能:行業紅利+硬核實力共振亮眼業績的背後,並非短期行情驅動,而是智能汽車賽道高景氣紅利與公司自身硬核核心實力雙向加持的結果。行業層面,當前智能汽車正加速從傳統交通工具向智能移動空間迭代,智能座艙已然成為新車標配,車載HUD從過往選配功能快速向全車系標配滲透。行業數據顯示,2020至2024年國內車載HUD銷量複合增速高達41.2%,行業增長勢頭強勁;展望未來,預計2029年國內車載HUD市場規模將擴容至1270萬台,行業高增長浪潮為公司業績持續上行築牢底層基石。而公司自身四大核心壁壘,更是超額跑贏行業增長的關鍵支撐:其一,全棧自研技術領先。公司具備光學、機械、電子、算法、HMI全鏈條研發能力,項目交付週期低至10個月,遠低於18個月的行業平均水平,技術差異化優勢顯著。其二,優質客戶資源穩固。公司深度綁定國內主流車企,客戶合作粘性強、客戶集中度處於合理區間,歷年定點訂單持續落地,業績基本盤堅實可靠。其三,產能佈局持續釋放。生產基地規模化投產,平台化研發拉高零件共用率,疊加量產效應持續優化生產成本,交付能力與盈利水平同步升級。其四,盈利結構持續優化。產品重心向高毛利AR-HUD傾斜,高端產品放量帶動整體毛利率改善,逐步跳出低端同質化競爭,盈利質量穩步提升。長期成長路徑清晰:訂單+技術+全球化三重打開空間立足中長期發展,澤景股份成長邏輯清晰完整,未來業績確定性與長期成長天花板同步打開。目前,公司在手訂單充裕,業績確定性拉滿,公司前期鎖定的各大車企定點項目正有序推進量產落地,存量訂單儲備充足,交付節奏穩步向好,為業績穩健增長提供堅實支撐。同時,公司前瞻佈局全息光學、光波導、RISD實像懸浮等下一代前沿車載視覺技術,持續拓展電子後視鏡、透明車窗顯示等創新業務;此外,公司深度融合AI技術,將AI算法嵌入AR-HUD場景融合、智能交互等核心環節,精准契合智能汽車AI化浪潮,持續強化產品核心競爭力,打開第二增長曲線。值得關注的是,澤景股份全球化佈局穩步推進,依託自研技術與成熟解決方案優勢,公司積極切入海外車企供應鏈,逐步搭建海外生產與業務網絡,加速從國內車載HUD龍頭向全球級汽車電子供應商跨越,海外市場增量空間廣闊,成為未來重要業績增長點。總體而言,澤景股份坐擁行業高景氣賽道,憑藉全棧技術壁壘、產品結構迭代升級、優質客戶資源積澱及全球化戰略佈局五大核心優勢,營收與盈利增長邏輯扎實清晰,公司中長期業績增長確定性突出、具備強勁可持續動能,作為港股AR交互第一股,未來成長潛力充沛,發展空間十分廣闊。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
IPO追蹤:香港最大藥品零售商龍豐集團招股在即 首8個月純利飆升85.8%
香港, 2026年5月26日 - (亞太商訊 via SeaPRwire.com) - 龍豐集團通過港交所上市聆訊,消息甫出,旋即引發港股投資圈的高度關注。大眾對龍豐集團絕不陌生,從遞交上市申請的一刻起,其每一步動向均牽動市場目光。如今港股市場即將迎來這位矚目新星,其背後的投資價值與增長潛力,值得我們深入探究。收入三年翻倍,盈利能力持續提升據招股書披露,龍豐集團近年業績增長強勁。於2023至2025財年,集團總收入由10.94億港元大幅增至24.61億港元,複合年增長率高達50%。於2026財年首8個月,總收入已達約20.35億港元,同比大幅增長34.7%,純利更躍升85.8%至約1.48億港元,盈利能力持續兌現。不僅如此,龍豐的增長質量亦遠超行業平均水平。於2023至2024財年期間,其美妝產品、保健產品及藥品收入錄得95.8%的增長率,大幅跑贏行業在2023年(19.0%)的平均增長率。在2025財年,龍豐進一步以5.2%的零售銷售額榮膺香港最大藥品零售商的寶座。龍豐以耀目的財務表現,印證其作為港股零售賽道「準巨頭」的硬實力。高分紅政策提振信心:上市後派息比例不低於50%除了強勁的業績增長,龍豐集團在股東回報方面同樣具備吸引力。招股書明確指出,公司董事會擬於上市後建議派發年度股息,金額不低於該年度可供分配予股東溢利的50%。這一清晰且高比例的派息比率,不僅體現了管理層對未來現金流的信心,也為投資者提供了可預期的穩定回報,進一步提升了本次發行的投資價值。從產品矩陣到門店網絡,再到供應鏈實力——龍豐集團的核心優勢拆解不同於傳統藥房或美妝店的有限陳列,龍豐集團的核心競爭力首先體現在其「寬到極致」的產品組合。根據招股書,於往績記錄期間,集團出售的產品SKU累計超過49,000個,涵蓋美容護膚產品、保健產品及補充品、藥品、母嬰產品、個人護理、食品甚至家居日用品等11大核心品類,部分大型旗艦店的SKU更高達13,000個,真正實現了「多一點選擇,多一點快樂」的一站式購物體驗。這種海量選品的規模效應,不僅構成了強大的供應鏈壁壘,更讓競爭對手難以複製。除了產品「多而全」,龍豐集團的線下網絡佈局同樣極具戰略眼光。截至最後實際可行日期,集團在香港共經營31間線下零售店,總可用樓面面積超過123,000平方呎,平均每間店舖超過4,000平方呎。其選址策略已從早期的社區滲透,升級為全面佔據核心黃金地段——無論是中環、尖沙咀、旺角,還是銅鑼灣等旅客及本地消費高密度區域,均能見到「龍豐」的身影。更值得關注的是,集團的擴張步伐從未停歇。據招股書披露,龍豐計劃於未來三個財政年度每年開設最多6-7間新零售店,進一步擴大網絡覆蓋。這種覆蓋旅遊區與商業區的門店矩陣,使其既能抓取龐大過境旅客流量,又能深度綁定本地高購買力家庭客群。支撐其產品多樣性與穩定貨源的核心,是龍豐集團深厚的供應鏈底蘊。按向藥房等傳統銷售渠道的年度總銷售額計,集團於2022年、2023年及2024年連續三年為香港Friso嬰幼兒配方奶粉產品的最大採購商;同時,亦連續三年為幸福醫藥旗下多款產品的最大採購商。此外,集團與幸福醫藥、樂信藥業、虎標、京都念慈菴等知名品牌商保持合作,為集團的貨源穩定性及產品品質提供了堅實保障。頂級保薦人護航:星展獨家保薦項目股價表現亮眼除了集團自身的基本面實力外,本次龍豐集團上市的獨家保薦人是極具往績的星展亞洲融資。星展上一次擔任獨家保薦人的項目——訊眾通信(2597.HK),去年上市後的股價表現堪稱亮眼,由13.55港元招股價升至最近超過40港元,相當於招股價的三倍。星展此番再度出手,獨家保薦龍豐集團衝擊港股,無疑為市場注入了一劑強心針。頂級投行的嚴苛篩選標準與過往項目的出色股價表現,從側面印證了龍豐集團的投資價值與成長潛力。隨著路演正式啟動,這家擁有逾30年行業經驗、橫跨美妝保健藥品三大賽道的香港零售標杆,即將迎來品牌與資本的雙重躍升。對於投資者而言,龍豐集團的登陸不僅是港股零售板塊的一次重要補強,更是一個兼具成長確定性與行業定價權的稀缺投資機會。未來已來,市場拭目以待。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
香港董事學會2026年度董事嘉獎現已接受提名
香港, 2026年5月26日 - (亞太商訊 via SeaPRwire.com) - 香港董事學會宣布,2026年度董事嘉獎現已開始接受提名。作為學會的年度代表性獎項,此項目將一如既往地成為在香港促進優秀企業管治與董事專業化發展的基石。今年的主題為「在充滿挑戰的環境中砥礪前行」(英文:Navigating Through Disruptive Forces in Challenging Times)。這主題完美彰顯了現代董事會所需具備的韌性 - 引領企業在急速的數位轉型、宏觀經濟轉變以及持份者期望不斷演變的浪潮中穩步前行。適逢董事嘉獎邁入第 26 屆,香港董事學會將再次頒發涵蓋三大管治核心範疇的標誌性獎項:「傑出董事獎」、「氣候管治獎」及「社會貢獻獎」。這些獎項不僅僅是簡單的表彰,更是為了讚揚那些將企業管治、氣候管治和社會可續性融入其核心業務架構的卓越領袖。香港董事學會主席曾立基先生在致辭中表示:「我們肩負企業管治的監督責任,需要平衡所有持份者的利益。今年的主題恰如其分地反映了當前的不確定環境 - 挑戰重重,但我們仍然堅定前行。透過這項極具影響力的舉措,我們深切致力於表彰業界典範、促進同儕互學,並全面提升香港企業管治的整體水平。」香港董事學會行政總裁謝達安先生介紹了 2026 年度董事嘉獎的核心亮點與安排,並鼓勵符合資格的候選人提前提交提名。歷屆得獎者分享見解簡報會設有「傑出董事見解」的小組討論,由獎項籌委會主席及理事陳永誠先生主持,三位歷屆傑出得獎者分享了他們如何透過嚴謹的董事會監督,將其轉化為企業韌性的經驗:- 豐盛生活服務有限公司執行董事李國邦先生強調面對技術變革時,前瞻性管治的迫切需求。他指出,進取型董事會必須主動擁抱科技,例如成立專門的人工智能(AI)委員會,有助於企業將數位工具無縫整合至成本分析及 ESG 追蹤等日常實踐中。- 東亞銀行有限公司集團總稽核李深女士探討在嚴格監管下如何強化風險與審計框架,強調董事會多元化,包括金融監管及網絡安全等領域,是有效管理不可預見風險及對管理層提出建設性挑戰的關鍵。- 奧雅納東亞區總裁楊詠珊女士分享了在大型基建及可持續發展項目中的領導經驗,指出董事會需將可持續性理念納入明確可行的企業指引和日常 KPI,而非僅停留於口號。得獎者同時提醒有意申請者,提名過程本身就是一次免費、全面的企業「健康檢查」,鼓勵候選人準備完整、量化資料,以佐證其成就。提名詳情及獎項類別2026年度所有獎項提名截止日期為 2026年7月23日。提名將由資深商界領袖、專業人士及監管代表組成的獨立評審團嚴謹評核。獎項類別如下:公司類別董事類別上市公司非上市公司法定/非分配利潤組織執行董事非執行董事董事會下載提名表格及詳情指南,請訪問官方 HKIoD 網站: https://www.hkiod.com/award-series-for-director-excellence-2026/.(從左至右) 香港董事學會獎項籌委會主席陳永誠先生主持互動小組討論,歷屆得獎者李國邦先生、李深女士及楊詠珊女士出席,分享企業領導及可持續管治的最佳實踐。香港董事學會(簡稱"HKIoD",又以下簡稱「學會」)香港董事學會為香港代表董事共同努力的首要組織,其宗旨是促進企業永續發展職能,為所有公司、其擁有者、持份者、人類以至地球創造持久價值;為達成使命,學會致力於企業管治(「企業管治」又稱「公司治理」)及董事專業行為上的倡導及釐定相關標準。學會於1997年由創會主席鄭慕智博士帶領下創始,多年來非常榮幸獲得香港特別行政區行政長官擔任學會贊助人。學會會員來自不同行業及公司類別,並包括執行董事、非執行董事、獨立非執行董事。學會以多元文化及國際視野進行會務,舉辦活動包括董事培訓課程、研討會與論壇、董事立場喉舌、指引設定、公眾教育、董事嘉獎系列、上市公司管治水平釐定等。作為「董事學會環球網絡」(Global Network of Director Institutes 簡稱"GNDI")的成員組織,學會投入全球性聯手推動優秀企業管治及董事專業行為。學會亦獲委派代辦「氣候管治行動」(Climate Governance Initiative)之香港分部,該行動是與「世界經濟論壇」(World Economic Forum)合作的環球網絡,積極促進董事們處理氣候變化帶來的風險與機遇。詳情請瀏覽:http://www.hkiod.com | http://www.gndi.org | https://climate-governance.org/2026年度董事嘉獎查詢: 新聞垂詢:香港董事學會 縱橫公共關係顧問集團有限公司蘇佩君odessa.so@hkiod.com 陳練brenda.chan@sprg.com.hk吳麗香 karen.ng@sprg.com.hk電話:+852 2889 4988 電話:+852 2114 4396/ 2114 4978傳真:+852 2889 9982 傳真:+852 2114 4948 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
The Hong Kong Institute of Directors Awards for Director Excellence 2026 Open for Nominations
HONG KONG, May 26, 2026 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Institute of Directors (HKIoD) has officially announced that nominations are now open for the HKIoD Awards for Director Excellence 2026. This flagship award programme continues to serve as a cornerstone for promoting outstanding corporate governance and director professionalism across Hong Kong.This year's Awards theme, Navigating Through Disruptive Forces in Challenging Times, underscores the resilience required by modern boards to steer their organisations steadily through rapid digital transformations, macroeconomic shifts, and evolving stakeholder expectations.In its 26th edition, HKIoD will once again present its signature accolades across three critical governance pillars: the Directors of the Year Award, the Climate Governance Award, and the Social Impact Award. These honours go beyond simple recognition; they celebrate visionary leaders who deeply embed corporate governance, climate governance, and social sustainability in the core of their business frameworks.Mr Richard Tsang, Chairman of HKIoD, during his keynote address, stated: "As fellow directors, we serve as stewards of corporate governance, tasked with balancing the interests of all stakeholders. This year’s theme perfectly captures the prevailing uncertainties we face today—times are undeniably tough, yet we continue to forge ahead with resolve. Through this impactful initiative, we remain deeply committed to honouring role models, fostering peer learning, and raising the overall standard of corporate governance in Hong Kong."Mr Jonathan Shea, CEO of HKIoD, introduced the key highlights and arrangements for the 2026 project cycle and encouraged eligible candidates to submit their nominations well ahead of the deadline.Insights from Distinguished Past AwardeesThe briefing session featured an insightful panel discussion, titled "Distinguished Directors' Insights", moderated by Mr Vincent Chan (Council Member & Chairman of the Awards Organising Committee). Three distinguished past awardees shared their experiences on how rigorous board oversight translates into organisational resilience:- Mr Alvin Lee (Executive Director, FSE Lifestyle Services Limited) highlighted the critical need for forward-looking governance in the face of technological shifts. He noted that boards must proactively embrace technology rather than passively approve management decisions. For instance, establishing dedicated AI committees can help organisations seamlessly integrate digital tools into daily practices like cost analysis and ESG tracking.- Ms Helen Li (Group Chief Auditor, The Bank of East Asia Limited) discussed strengthening risk and audit frameworks under stringent regulatory landscapes. She emphasised that true board diversity—compassing expertise across such areas as financial oversight and cybersecurity—is essential for managing unpredictable "unknown unknowns" and allowing directors to constructively challenge executive management.- Ms Theresa Yeung (Managing Principal, East Asia, Arup) shared her extensive experience steering massive infrastructure and sustainability initiatives. She explained that when driving deep organisational change, boards must look beyond simple slogans and explicitly hardcode sustainable concepts into clear, actionable checklists and daily KPIs.The panel collectively reminded prospective applicants that the assessment process functions as a free corporate "health check". Nominees are strongly encouraged to prepare robust, quantitative data to back up their achievements for review by the independent judging panels.Nomination Details & CategoriesThe deadline for submitting all nominations for the 2026 Awards is 23 July 2026. The nominations will be rigorously evaluated by a highly credible panel of prominent business leaders, professionals, and regulatory representatives.Awards are granted across the following categories:Company CategoriesDirector CategoriesListed CompaniesNon-Listed CompaniesStatutory / Non-Profit OrganisationsExecutive DirectorsNon-Executive DirectorsBoard of DirectorsTo download nomination forms and access detailed guidelines, please visit the official HKIoD portal: https://www.hkiod.com/award-series-for-director-excellence-2026/.Photo Caption: (Left to Right) HKIoD Awards Organising Committee Chairman Mr Vincent Chan hosts the interactive panel discussion alongside past awardees Mr Alvin Lee, Ms Helen Li, and Ms Theresa Yeung, highlighting best practices in corporate leadership and sustainable governance.About The Hong Kong Institute of Directors (“HKIoD”)The Hong Kong Institute of Directors (“HKIoD”) is Hong Kong’s premier body representing directors working together to advance corporate sustainability in creating long-term value for companies, their owners, stakeholders, humankind and Planet Earth through advocacy and standards-setting in corporate governance and director professionalism. Led by Founder Chairman Dr The Hon Moses Cheng, HKIoD was founded in 1997. Throughout the years, HKIoD is honoured to have the Chief Executive of HKSAR as the Institute’s Patron. Membership of HKIoD comprises of directors from diverse industries and corporate types and includes Executive Directors, Non-Executive Directors and Independent Non-Executive Directors. With multi-culturalism and international perspectives, HKIoD organises activities that cover director training, seminars and forums, collective director voice, guideline establishment, public education, Award Series for Director Excellence, assessment of Corporate Governance Scorecard for listed companies etc. As a member body of the Global Network of Director Institutes (“GNDI”), HKIoD is committed to global collaboration in promoting good corporate governance and director professionalism. HKIoD is the appointed Host of the Hong Kong Chapter of Climate Governance Initiative, a global network that collaborates with the World Economic Forum in actively promoting directors’ address of the risks and opportunities of climate change.For details please visit: http://www.hkiod.com | http://www.gndi.org | https://climate-governance.org/Awards Enquiries: Media Enquiries:The Hong Kong Institute of Directors Strategic Public Relations GroupOdessa So Brenda Chan / Karen Ng+852 2889 4988 / odessa.so@hkiod.com +852 2114 4396 / 2114 4978brenda.chan@sprg.com.hkkaren.ng@sprg.com.hkFax:+852 2889 9982 Fax:+852 2114 4948 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Sentire思騰(R)腔鏡手術機械人獲歐盟CE與新加坡HSA雙認證, 康諾思騰(Cornerstone Robotics)全球化戰略全面提速
香港, 2026年5月26日 - (亞太商訊 via SeaPRwire.com) - 香港創新型手術機械人企業康諾思騰(Cornerstone Robotics)欣然宣布,其自主研發的 Sentire思騰(R)腔鏡手術機械人,成功獲得歐盟《醫療器械法規》(CE MDR)權威認證,並同步取得新加坡衞生科學局(HSA)認證,兩項認證均涵蓋泌尿外科、普通外科、婦科及胸外科等微創手術領域。這次雙里程碑式的突破,標誌著Sentire思騰(R)正式獲准進入歐洲與亞太地區的核心醫療市場。康諾思騰亦成為首個同步完成歐盟法規認證與深度歐洲臨床驗證的香港手術機械人品牌,彰顯本港自主研發的高品質醫療器械已進駐國際市場主賽道。 首個香港品牌完成歐盟法規與臨床雙認證Sentire思騰(R)手術機械人深度融合了臨床醫學、精密工程、前沿軟件及超高清影像技術,屬頂尖的高端醫療系統平台。此次成功獲得歐盟CE認證,不僅證明了其安全性、臨床有效性及質量管理等關鍵領域,已全面達到國際主流的合規標準,更標誌著這項高品質自主研發平台,已具備全方位服務全球醫患的卓越實力與專業資格。公司早前於英國倫敦和樸次茅斯設立分支機構,並依託全球三大研發中心的協同體系,持續吸納歐洲頂尖科研人才與豐富臨床資源,為產品技術升級與臨床適用度注入國際化創新動能。自2025年起,康諾思騰攜手英國樸次茅斯大學醫院NHS基金信托(Portsmouth Hospitals University,PHU)啟動Sentire思騰(R)的臨床評估項目,持續累積歐洲真實臨床數據,為循證研究、系統化培訓及臨床應用推廣提供堅實支持。截至目前,Sentire思騰(R)已在英國成功完成涵蓋泌尿外科、胃腸外科、婦科等核心科室的複雜手術临床试验,其在應對各類手術環境時的卓越穩定性與廣泛適用性,獲得海外臨床專家高度肯定與此同時,新加坡衞生科學局(HSA)認證於亞太區享有極高國際公信力,向來引領全球主流醫療安全與成效的標準。Sentire思騰(R)此次同步獲得歐盟與新加坡雙重權威認證,充分彰顯其在全球不同監管體系下的卓越實力,亦印證了這項本港自主研發技術的成熟度,高品質水平廣受國際醫療界肯定。深耕全球市場,打造一站式本地化服務秉承「立足香港,放眼全球」的戰略視野,康諾思騰在香港投資管理有限公司(港投公司)的戰略注資支持下,正積極深化全球本地化佈局,以專業深度賦能全球醫患。在歐洲市場,公司於2025年正式成立英國子公司,積極構建涵蓋售前專業培訓、臨床技術支援、以及售後保障的全週期一站式本地化服務體系。康諾思騰已在英國順利開展多場系統化培訓,對象涵蓋外科醫生、手術室護理團隊及醫院技術支援人員,全力推動臨床團隊迅速掌握操作系統的熟練度並建立使用信心,為後續的規模化商業推廣構築穩固基石。在持續深化歐洲佈局的同時,康諾思騰亦積極拓展亞太區內合作網絡。公司早前與新加坡國立健保集團(NHG)及南洋理工大學李光前醫學院(LKC Medicine)正式簽署三方戰略合作備忘錄,共同推進新加坡醫療創新生態體系建設;並於2026年4月,於NHG旗下的兀蘭醫院(Woodlands Hospital)成功設置當地首台Sentire思騰(R),正式進駐新加坡醫療系統。作為進駐當地的首台系統,Sentire思騰(R) 將面向當地多家醫院的外科團隊開放,全面賦能前線醫護進行系統化操作培訓與臨床流程適配,在科研與教學場景中率先發揮卓越效能,穩步推動手術機械人創新應用在新加坡長遠發展。全自主研發與垂直整合 構築引領國際市場的技術根基康諾思騰始終堅持全方位自主研發與垂直整合的長期戰略,成功搭建覆蓋機械、電機、軟件、算法,以及視覺影像技術等核心技術的全面底層技術平台。高度的技術自主可控,不僅帶來了卓越的臨床表現,確保了供應鏈的自主性與高度穩定,亦大幅提升了未來科研創新的敏捷度與戰略高度。基於全自主研發與垂直整合所構築的高品質技術系統,讓Sentire思騰(R)在各類複雜手術中,均能展現出色的穩定性與精準可控的表現。康諾思騰創始人兼首席執行官歐國威教授表示:「榮獲歐盟CE及新加坡HSA認證,是康諾思騰從技術深耕邁向全球臨床應用的重要里程碑。從在英國樸次茅斯開展首次臨床驗證,到如今順利取得多個關鍵區域的市場批准,每一步都凝聚著團隊對自主創新與臨床價值的執着。我們堅信,在競爭激烈的國際市場中,贏得長期信賴的核心在於卓越的產品品質與紮實的臨床表現。未來,我們將持續深耕全球核心醫療市場,依託專業的本地化團隊與一站式服務體系,並與全球頂尖醫療機構攜手,為更多醫患提供高品質的手術機械人解決方案。」這項雙重認證的落地,不僅是Sentire思騰(R)奠定進入歐洲及亞太市場的重要起點,更標誌著康諾思騰全球化計劃進入加速階段。而資本層面的戰略支持亦為康諾思騰全球化佈局注入強勁動能。2025年11月,康諾思騰完成約2億美元超募融資,由港投公司領投,並獲全球戰略投資者與全球頂級主權基金共同參與。港投公司作為香港特區政府全資擁有的「耐心資本」投資機構,其注資彰顯市場對公司全球商業化實力與長遠發展前景的信心,同時體現特區政府對本地創新科技企業的肯定與堅實支持,為公司拓展歐洲及亞太市場提供雄厚資源保障。立足於堅實的技術基礎與充裕資源,公司將持續推動Sentire思騰(R)的臨床應用拓展與技術優化,並以歐洲及亞太市場為戰略支點,逐步構建覆蓋全球的國際創新協作網絡,為全球外科醫生提供更精準可靠的手術機械人解決方案,為全球患者帶來更高質量的生命守護。關於康諾思騰(Cornerstone Robotics)康諾思騰(Cornerstone Robotics)是於中國香港成立並完成孵化的創新型手術機械人企業,懷著「引領醫療創新,心繫天下健康」的願景,致力於打造安全高效的手術機械人平台,提升全球範圍優質醫療資源的可及性,讓更多患者受益於高端醫療科技帶來的高品質醫療服務。公司已在全球設立三大研發中心,並在中國香港、深圳、北京、上海、英國倫敦和樸次茅斯等地設有分支機構,在粵港澳大灣區建成30,000平米的量產工廠。憑藉雄厚的技術實力,公司已成功攻克技術難題,搭建起全面底層技術平台,由康諾思騰自主研發的Sentire思騰(R)腔鏡手術機械人已完成多個重要專科的臨床試驗,並在中國、歐盟、新加坡等多個國家與地區獲批上市,服務全球醫護,惠及更多病患。如欲瞭解更多,可瀏覽:https://www.csrbtx.com Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Sentire(R) Surgical System Receives EU CE Mark (MDR) and Singapore HSA Approval, Cornerstone Robotics Accelerates Global Strategic Expansion
HONG KONG, May 26, 2026 - (ACN Newswire via SeaPRwire.com) - Cornerstone Robotics, a leading innovator in surgical robotics based in Hong Kong, is pleased to announce that its proprietary Sentire(R) Surgical System has officially received European Union CE mark certification under the Medical Device Regulation (MDR) and has simultaneously obtained approval from the Health Sciences Authority (HSA) of Singapore. These certifications cover minimally invasive surgical procedures in General Surgery, Gynecology, Thoracic and Urology. This milestone marks the formal entry of the Sentire(R) Surgical System into the core medical markets of Europe and the Asia-Pacific. Cornerstone Robotics has thus become the first Hong Kong-based surgical robotics brand to simultaneously complete EU regulatory certification and in-depth European clinical validation, signaling that Hong Kong’s high-quality medical device innovation has officially entered the international market’s main track. Achieving Combined Regulatory Approval and Clinical ValidationThe Sentire(R) Surgical System is a high-end surgical robotic platform that combines clinical workflows with integrated engineering, software, and imaging technologies. Achieving CE certification not only demonstrates that its safety, efficacy, and quality management system fully comply with stringent international regulatory standards but also affirms that this high-quality platform possesses the robust capability and credentials to serve physicians and patients worldwide.Alongside regulatory certification, Cornerstone Robotics has simultaneously advanced its international clinical validation. By leveraging its three global R&D centres and establishing an early presence in the UK, the Company has integrated European talent and clinical resources to inject international innovation momentum into product iteration and clinical adaptation. Since 2025, the Company has partnered with Portsmouth Hospitals University NHS Trust (PHU) to undertake a fully compliant clinical investigation for the Sentire(R) Surgical System, steadily accumulating real-world European clinical data to support evidence-based research, training protocol development, and clinical adoption. To date, the Sentire(R) Surgical System has successfully completed numerous complex procedures in the UK, spanning core specialties including urology, gynecology, and upper and lower gastrointestinal surgery. The investigation achieved positive patient outcomes, and the clinicians were very satisfied with the system’s performance. Concurrently, the Singapore HSA certification, as one of the highly mature and internationally recognised medical device market access systems in the Asia-Pacific, is similarly renowned for its rigorous safety and efficacy evaluations. The Sentire(R) Surgical System's simultaneous achievement of certifications from both the EU and Singapore fully demonstrates Cornerstone Robotics' quality and compliance across different global regulatory frameworks.Deepening Global Presence with One-Stop Localised ServicesAdhering to its “From Hong Kong to the World” strategy, Cornerstone Robotics has deepened its global localisation efforts with the strategic support of the Hong Kong Investment Corporation (the HKIC), aiming to empower physicians and patients worldwide through professional service. In the European market, to further support regional customers and enhance clinical responsiveness, the Company established its UK subsidiary in 2025, initiating a one-stop service provision encompassing professional training, clinical technical support, and after-sales service. The Company has already completed multiple training sessions in the UK, covering surgeons, operating room nursing teams, and hospital technical support personnel, helping clinical teams rapidly build proficiency and confidence in operating the Sentire(R) Surgical System, thereby establishing a solid foundation for scaled commercial rollout.While continuing to deepen its European footprint, Cornerstone Robotics has also been actively expanding its Asia-Pacific collaboration network. Previously, Cornerstone Robotics signed a tripartite Memorandum of Understanding (MOU) with the National Healthcare Group (NHG) and the Lee Kong Chian School of Medicine (LKC Medicine) of Nanyang Technological University, Singapore, to jointly advance the development of Singapore's healthcare innovation ecosystem. In April 2026, Cornerstone Robotics completed the first installation of the Sentire(R) Surgical System in Singapore at Woodlands Hospital under NHG. The system is being made available to surgical teams from multiple local hospitals for system testing, operation training and clinical workflow adaptation assessments. This deployment leverages the system’s performance in research and training, steadily advancing the adoption of innovative surgical robotic applications in Singapore and the broader Asia-Pacific region.Full-Stack In-House R&D and Vertical Integration: The Foundation for High-Quality Global ExpansionCornerstone Robotics has consistently adhered to the long-term strategy of full-stack in-house R&D and vertical integration, which forms the foundation of its competitive advantage and high-quality international expansion. Anchored in this strategy, the Company has successfully built an underlying technology platform spanning mechanical, electrical, software, algorithmic, and vision imaging technologies. This high degree of technological autonomy ensures superior clinical performance, secures supply chain resilience, and enhances the agility and long-term innovation potential of its R&D. Built upon this vertically integrated architecture, the Sentire(R) Surgical System delivers exceptional stability and predictable performance in demanding surgical environments.Professor Samuel Au, Founder and CEO of Cornerstone Robotics, commented: “Receiving both EU CE and Singapore HSA certifications marks a major milestone in Cornerstone Robotics' evolution from technology innovator to a global clinical solution provider. From our first clinical investigation in Portsmouth, UK, to formally securing multi-jurisdictional regulatory approvals, every step of the journey reflects our commitment to proprietary innovation, product excellence, and clinical value. Looking ahead, we will continue expanding into key global markets and partnering with leading medical institutions to bring advanced surgical robotic solutions to more physicians and patients worldwide.”The successive approvals of both EU CE and Singapore HSA certifications represent not only important market access gateways for the Sentire(R) Surgical System, but also a signal that Cornerstone Robotics' globalisation strategy has entered an accelerated phase. Strategic capital support has injected further momentum into this global push. In November 2025, Cornerstone Robotics successfully completed an oversubscribed financing round of approximately US$200 million, led by the HKIC with participation of global strategic investors and top-tier sovereign funds. As a flagship “patient capital” investor wholly owned by the HKSAR Government, the HKIC’s investment underscores market confidence in Cornerstone Robotics' global commercial capabilities and long-term growth prospects. With the European and Asia-Pacific markets as strategic anchors, Cornerstone Robotics is delivering more precise and reliable robotic solutions to physicians worldwide and extending higher-quality life protection to patients across the globe.About Cornerstone Robotics (CSR)Established and incubated in Hong Kong, Cornerstone Robotics (CSR) is an innovative surgical robotics unicorn driven by the vision of leading medical innovations for a healthier world. It advances surgical care with cutting-edge robotic systems that make high-quality healthcare more accessible and efficient globally. With three global R&D hubs and six business centers worldwide, the company has established a 30,000-square-meter manufacturing facility in China. Developed entirely in-house, its Sentire(R) surgical system has successfully completed multi-specialty clinical trials and received market approval in multiple countries and regions, including China, the European Union and Singapore, serving medical professionals globally and bringing better care to more patients.To find out more information, please visit our website at https://en.csrbtx.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
How to Manage Large Purchases During Sale Season Responsibly
SINGAPORE, May 25, 2026 - (ACN Newswire via SeaPRwire.com) - Sale seasons in Singapore, such as the Great Singapore Sale or the year-end 12.12 events, offer significant opportunities to save on high-ticket items. However, the pressure of flash deals and limited-time offers can easily lead to impulsive overspending. Managing these large purchases responsibly requires disciplined planning and using financial tools like quick loans to maintain your long-term stability.Selecting a flexible credit line or quick loans may provide access to funds that can be considered as part of managing expenses during sale periods. This approach may help you with short-term cash flow management while meeting daily expenses. The following strategies focus on how to navigate major sale events while keeping your financial health intact.Create a prioritised shopping listBefore the sales begin, you should identify what you truly need versus what you simply want. A common mistake is falling into the trap of discount illusion, where buying a discounted item you do not actually need is viewed as a saving when in reality, it is an unnecessary expense.List your intended large-scale purchases in a spreadsheet, noting their original prices and the stores that sell them. Prioritise these items based on their utility and longevity, such as essential home appliances or quality electronics. This preparation allows you to act decisively on genuine deals while ignoring filler items that only serve to drain your budget.Set a hard budget capThe excitement of a sale can often cloud your financial judgment, leading to multiple impulsive purchases, thus making you lose track of your total expenses. To avoid this, determine a realistic total amount you are willing to spend across the entire sale season.If your high-priority items exceed your current cash in hand, you might consider using quick loans to bridge the gap. A flexible credit line can offer immediate access to funds, but you must ensure the total loan amount fits within your calculated repayment capacity. Establishing this limit early may help you not to fall short of funds for the remainder of the month due to a single weekend of shopping.Use flexible financing to control cash flowLarge purchases often require significant upfront cash that can temporarily destabilise your monthly balance. In such cases, quick loans or a personal line of credit can serve as a valuable tool for managing short-term cash flow.Some credit lines may offer promotional interest rates of up to 0% interest for several months, subject to applicable terms and conditions. This flexibility allows you to secure the sale price of a large item immediately while spreading the cost over a few months. Repaying the balance quickly may help you benefit from the sale discount without losing those savings to interest charges.Think twice before you payFlash sales and discount banners are designed to trigger a fear of missing out, thus forcing you to act in haste. One of the effective ways to counteract this is the 24-hour rule: wait a full day before proceeding to purchase any non-essential large item.Giving yourself this time allows the initial emotional impulse to fade, helping you decide if the item truly adds value to your life. If the deal is still available and fits your budget the next day, you can proceed with confidence. This simple pause can save you a lot of funds and from buyer's remorse in the foreseeable future.Focus on quality and long-term valueA low price tag does not always equal a good deal if the product requires frequent repairs or expensive maintenance. When shopping for large items during a sale, prioritise quality over quantity by researching product reviews and warranties.Investing in a durable, high-quality appliance, even at a slightly higher sale price, often costs less in the long run than a cheaper, lower-quality alternative. Additionally, always check return policies before purchasing, as being stuck with a non-returnable faulty item can turn a temporary bargain into a long-term loss.Final thoughtsManaging large purchases during Singapore's sale seasons is about making informed decisions that align with your financial goals. By using a structured plan and leveraging tools like quick loans responsibly, you can enjoy the full benefits of a sale without lingering financial distress.Disclaimer: This content is published by iQuanti Singapore Pte Ltd, an external marketer engaged and compensated by UOB Ltd.Contact Information:Name: Sonakshi MurzeEmail: Sonakshi.murze@iquanti.comJob Title: ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
宇樹科技IPO上會在即 首程控股(697.HK)機器人資產迎估值重估
香港, 2026年5月26日 - (亞太商訊 via SeaPRwire.com) - 首程控股(697.HK)在機器人產業鏈的前瞻布局,正迎來新的估值催化。5月25日,上交所官網顯示,上海證券交易所上市審核委員會定於2026年6月1日召開2026年第31次審議會議,審議宇樹科技股份有限公司科創板首發上市申請。作為國內具身智能與人形機器人領域的代表性企業,宇樹科技IPO進程穩步推進,有望提升機器人產業鏈在資本市場的關注度,也將為首程控股相關機器人資產提供更清晰的估值參照。公開資料顯示,宇樹科技科創板IPO申請已於今年3月20日獲上交所受理,擬募集資金42.02億元。按新股發行不低於發行後總股本10%測算,宇樹科技對應整體發行估值不低於420億元人民幣。首程控股通過北京機器人產業發展投資基金參與宇樹科技投資,該基金在宇樹科技發行前持股3.8262%,發行後持股比例約3.44%。按上述估值測算,該部分股權對應價值約14.46億元人民幣。對首程控股而言,宇樹科技上會意味著其機器人產業投資進入價值驗證階段。近年來,公司圍繞具身智能、服務機器人及商業化應用場景持續布局,逐步構建「產業基金投資+線下場景落地+資本化退出」的綜合模式。若宇樹科技順利上市,將有助於提升首程控股機器人資產的可視化估值,並增強市場對其產業投資能力的認可。整體來看,宇樹科技IPO為首程控股打開產業催化與估值重估窗口,公司中長期估值彈性有望進一步釋放。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Unitree Robotics IPO Review Approaches, Shoucheng Holdings Robot Assets Poised for Valuation Re-rating
HONG KONG, May 26, 2026 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings (697.HK) is seeing a new valuation catalyst from its forward-looking deployment across the robotics industry chain. On May 25, information on the Shanghai Stock Exchange website showed that the SSE Listing Review Committee is scheduled to hold its 31st review meeting of 2026 on June 1, 2026, to review the STAR Market IPO application of Unitree Robotics Co., Ltd. As a representative company in China’s embodied intelligence and humanoid robotics sectors, Unitree Robotics’ steady IPO progress is expected to raise capital-market attention toward the robotics value chain and provide a clearer valuation reference for Shoucheng’s related robotics assets.Public information shows that Unitree Robotics’ STAR Market IPO application was accepted by the SSE on March 20 this year, with planned fundraising of RMB4.202 billion. Based on the assumption that the new shares will account for no less than 10% of the post-issue share capital, Unitree Robotics would have an implied post-issue valuation of no less than RMB42.0 billion. Shoucheng Holdings participates in the investment in Unitree Robotics through the Beijing Robotics Industry Development Investment Fund. The fund held 3.8262% of Unitree Robotics before the offering and is expected to hold approximately 3.44% after the offering. Based on the above valuation estimate, the corresponding value of this equity stake would be about RMB1.446 billion.For Shoucheng Holdings, Unitree Robotics’ upcoming review means that its robotics industry investment is entering a value-validation stage. In recent years, the company has continued to deploy capital and resources in embodied intelligence, service robots and commercial application scenarios, gradually building an integrated model of industrial fund investment, offline scenario implementation and capital-market exits. If Unitree Robotics is successfully listed, it will help enhance the visible valuation of Shoucheng’s robotics assets and strengthen market recognition of its industrial investment capabilities. Overall, Unitree Robotics’ IPO creates a clear industrial catalyst and valuation re-rating window for Shoucheng, with the company’s medium- to long-term valuation upside expected to be further unlocked. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
HONG KONG, May 22, 2026 - (ACN Newswire via SeaPRwire.com) - Patents are the key assets of technology enterprises, a solid moat for defending against market competition, and an important yardstick for measuring an enterprise's technical strength and seizing market dominance. At a time when the intelligent vehicle industry is accelerating iteration and intelligent cockpit interaction experience has become a core decision-making factor for users, HUD, as the core interactive terminal of intelligent cockpits, has become a key track for automakers' differentiated competition. The depth, breadth and accuracy of patent layout directly determine an enterprise's position and long-term development ceiling in the industry.As the first Hong Kong-listed stock in AR interaction, New Vision (02632.HK) has always adhered to the development strategy of "R&D-driven and innovation-led", continuously increased R&D investment, and built a comprehensive, in-depth and globally radiating patent system, laying a solid foundation for the Company to maintain technological leadership and lead industry development for a long time.Upgrading and Expanding Patent Layout, Core Technologies Leading the IndustryIn 2025, New Vision maintained strong innovation vitality, with 151 new patent applications filed throughout the year, achieving remarkable results in the commercialization of innovative achievements. As of December 31, 2025, the Company had obtained 228 valid patents in total. Its patents and pending applications cover key areas of the entire industrial chain such as HUD optical systems, mechanical structures, software interaction, electronic circuits, testing equipment and methods, forming an all-round, multi-level and comprehensive technical protection network and keeping core technologies firmly in its own hands.In terms of patent structure, the Company focuses on breakthroughs in high-end technologies, with a high proportion of invention patents in the industry. It has focused on laying out hardcore technical patents such as underlying optics, algorithms and core devices to build solid core technical barriers. Meanwhile, it has coordinated the layout of utility model and design patents, balancing product structure optimization, practical application and terminal visual experience, realizing the resonance between technological innovation and market demand.In terms of technical layout, the Company has deeply cultivated four core advantageous fields: optical imaging, AR algorithms, eye box adaptation and system reliability. It has targeted long-standing industry pain points such as blurred imaging, limited field of view, poor adaptability and insufficient stability in extreme environments, continuously strengthened differentiated technical barriers, and built an insurmountable innovative advantage for competitors.Meanwhile, New Vision is accelerating the internationalization of patents. Through the PCT international patent application channel, it has launched the construction of an intellectual property protection system, and gradually built a patent network covering major automotive markets such as Asia, Europe and North America. This global patent layout not only further consolidates the Company's international competitive barriers but also provides solid intellectual property protection for overseas market expansion, laying an important foundation for the Company's localized global operations.Precise Positioning of Core Patents, Tackling Frontier Technologies to Break Industry MonopolyDifferent from the general patent layout in the industry, New Vision focuses more on tackling high-value core patents and precisely positions core technologies and next-generation technology trends in the AR-HUD track.The Company's self-developed bifocal plane AR-HUD mass production technology, relying on its complete independent patent system, solves industry pain points of traditional single-focal-plane HUD such as short imaging distance, poor virtual-real integration and insufficient multi-scenario adaptation. It enables layered imaging of far and near scenes, improving the safety and intelligent experience of vehicle interaction. At present, this technology has been mass-produced on a large scale, becoming a benchmark product for domestic high-end AR-HUD.In the global patent layout, the Company has made advance arrangements for AR-HUD-related technologies, providing core technical patent endorsement for product overseas expansion and building core intellectual property barriers for its participation in competition in the global high-end vehicle interaction market.Empowering Development Through Patents, Industrialization Achievements Highlighting Core CompetitivenessThe strategic significance of patent layout has been fully reflected in the development of New Vision, becoming the core driving force for its high-quality development.First, breaking foreign monopoly and realizing independent control of HUD core technologies. In the past, the vehicle HUD market was long monopolized by Japanese and German enterprises, with prominent "bottleneck" problems in core technologies. Through continuous patent layout and technological innovation, New Vision has gradually got rid of its dependence on foreign capital technologies, provided domestic automakers with independently controllable high-end visual interaction products, and promoted the independent development of China's vehicle HUD industry.Second, building a solid technical moat and consolidating industry-leading position. Through an all-round and multi-level patent layout, New Vision can effectively prevent competitors from imitating technologies and continuously maintain industry-leading technological advantages. Relying on the dual advantages of patented technologies and mass production capacity, the Company has so far obtained 106 vehicle models, covering 23 leading mainstream OEMs. Its market share has steadily increased, making it a benchmark enterprise with excellent technology, scale and reputation in the domestic vehicle AR-HUD field.Third, supporting the implementation of global strategy and accelerating overseas market expansion. Based on PCT international patent layout, the Company has built a patent protection network covering major global markets, escorting product overseas expansion and overseas localized operation. It is reported that New Vision has set up subsidiaries in Germany, Hungary and Japan, initially realizing the transformation of localized global operations. It is continuously expanding its global market territory and enhancing the global influence of China's AR interaction technologies.Efficient Industrialization of Patents, Realizing Commercial Closed-Loop Through Technology Value TransformationDifferent from some pure technology enterprises and pure technology R&D enterprises that emphasize R&D but neglect application, New Vision's core competitiveness lies in the efficient transformation and industrialization of patented technologies. The Company has built a closed-loop transformation system of "patented technologies - mass-produced products - market application", realizing efficient linkage among intellectual property rights, core technologies and commercial value. It has rapidly applied core patented technologies to its two core product matrices, CyberLens and CyberVision. Core products such as bifocal plane AR-HUD and local dimming PGU have achieved large-scale mass production, demonstrating the commercial value of patented technologies.Meanwhile, the application of patented technologies has not only greatly improved core product performance and successfully solved industry pain points such as sunlight backflow, blurred imaging and extreme environment adaptation, but also achieved precise cost control through platform-based design and technical optimization, enhanced product cost performance, helped HUD products quickly penetrate from luxury models to the mass market, and unlocked incremental opportunities in the 100-billion-level vehicle interaction market.In addition, New Vision's core patents also have broad space for external licensing and technical cooperation. Through diversified cooperation modes such as patent licensing, joint technology development and joint R&D, the Company is expected to further explore the derivative value of intellectual property rights, open up new profit spaces, effectively hedge operational risks in a single product market, and further enhance the Company's risk resistance capacity and long-term profitability.From the perspective of industry development, as a leading enterprise in AR interaction, New Vision builds core competitiveness with patents and breaks the industry ceiling with technical reserves. Through precise, three-dimensional and global intellectual property layout, it continuously expands the technical boundary of vehicle AR interaction. The Company has not only broken foreign technological monopoly but also promoted China's AR interaction technology to gradually move onto the global stage. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Sentire(R) Surgical System Receives CE Mark (MDR) and Singapore HSA Dual Certification, Cornerstone Robotics Enters a New Era in its Global Expansion
HONG KONG, May 25, 2026 - (ACN Newswire via SeaPRwire.com) - Cornerstone Robotics (“CSR”), a leading global innovator in surgical robotics based in Hong Kong, China, is pleased to announce that its Sentire(R) Endoscopic Surgical System (hereinafter “Sentire(R) Surgical System”) has officially received European Union CE mark certification under the Medical Device Regulation (MDR) and simultaneously obtained Singapore Health Sciences Authority (HSA) certification, both covering minimally invasive surgical procedures in General Surgery, Gynecology, Thoracic and Urology. This milestone formally grants the Sentire(R) Surgical System access to both the European and Asia-Pacific markets.Achieving Combined Regulatory Approval and Clinical ValidationThe Sentire(R) Surgical System is a high-end surgical robotic platform that combines clinical workflows with integrated engineering, software, and imaging technologies. Achieving CE certification affirms that its safety, efficacy, and quality management system comply with stringent regulatory standards and is now positioned to serve physicians and patients worldwide.The Company established an early presence in the UK. Since 2025, CSR has partnered with Portsmouth Hospitals University NHS Trust (PHU) to undertake a fully compliant clinical investigation of the Sentire(R) Surgical System, steadily accumulating real-world clinical data to support evidence-based research, training protocol development, and clinical adoption. To date, the Sentire(R) Surgical System has completed numerous complex procedures in the UK, spanning core specialties including urology, gynecology, and upper and lower gastrointestinal surgery. The investigation achieved the patient outcomes and the clinicians were very satisfied with the system's performance. Concurrently, the Singapore HSA certification, as one of the highly mature and internationally recognised medical device market access systems in the Asia-Pacific, is similarly renowned for its rigorous safety and efficacy evaluations. The Sentire(R) Surgical System's simultaneous achievement of certifications from both the EU and Singapore fully demonstrates Cornerstone Robotics' quality and compliance across different global regulatory frameworks.Deepening Global Presence with Localised ServicesFrom its inception, CSR has embraced a ‘think global, act local’ approach — pursuing a global strategy empowered by local physicians and patients. In Europe, CSR formally established its UK subsidiary in 2025, initiating a one-stop service provision encompassing professional training, clinical technical support, and after-sales service. The Company has already conducted multiple training sessions in the UK, helping clinical teams rapidly build proficiency and confidence in operating the Sentire(R) Surgical System, thereby establishing a solid foundation for scaled commercial rollout.While continuing to deepen its European footprint, Cornerstone Robotics has also been actively expanding its Asia-Pacific collaboration network. Previously, Cornerstone Robotics signed a tripartite Memorandum of Understanding (MOU) with the National Healthcare Group (NHG) and the Lee Kong Chian School of Medicine (LKC Medicine) of Nanyang Technological University, Singapore, to jointly advance the development of Singapore's healthcare innovation ecosystem. In April 2026, Cornerstone Robotics completed the first installation of the Sentire(R) Surgical System in Singapore at Woodlands Hospital under NHG. The system is being made available to surgical teams from multiple local hospitals for system testing, operation training and clinical workflow adaptation assessments. This deployment leverages the system’s performance in research and training, steadily advancing the adoption of innovative surgical robotic applications in Singapore and the broader Asia-Pacific region.Full-Stack In-House R&D and Vertical Integration: The Foundation for High-Quality Global ExpansionCSR’s full-stack in-house R&D capabilities and vertically integrated model are the foundation of its competitive advantage and global growth strategy. The Company’s high level of technological integration not only drives strong clinical performance, supply chain resilience, and operational stability, but also enhances agility and supports long-term innovation.Professor Samuel Au, Founder and CEO of Cornerstone Robotics, commented: “Receiving EU CE and Singapore HSA certifications marks a major milestone in Cornerstone Robotics’ evolution from a technology innovator to a global clinical solutions provider. From our first clinical investigation in Portsmouth, UK, to achieving European regulatory approval, each step of the journey reflects our commitment to proprietary innovation, product excellence, and clinical value. Looking ahead, we will continue expanding into key global markets and partnering with leading medical institutions to bring high-quality surgical robotic solutions to more physicians and patients worldwide."The successive approvals of both EU CE and Singapore HSA certifications not only enable market access for the Sentire(R) Surgical System across Europe and Asia-Pacific, but also mark a major milestone in Cornerstone Robotics’ global expansion. In November 2025, the Company successfully completed an oversubscribed financing round of approximately US$200 million, underscoring strong confidence from leading international investors in its long-term growth potential and global commercial capabilities. Supported by proprietary technological innovation and strong strategic resources, Cornerstone Robotics is well positioned to accelerate the global adoption of high-quality, accessible surgical robotic solutions for physicians and patients worldwide.About Cornerstone Robotics (CSR)Cornerstone Robotics (CSR) is an innovative surgical robotics unicorn driven by the vision of leading medical innovations for a healthier world. It advances surgical care with cutting-edge robotic systems that make high-quality healthcare more accessible and efficient globally. With three global R&D hubs and six business centers worldwide, the company has established a 30,000-square-meter manufacturing facility in China. Developed entirely in-house, the Sentire(R) Surgical System has completed multi-specialty clinical trials and received market approval across China, the European Union and Singapore, advancing high-quality surgical care worldwide.To find out more information, please visit our website at https://en.csrbtx.com/For media inquiries, please feel free to contact Public Relations and Brand Communication Department of Cornerstone Robotics.Email: branding@csrbtx.com Website: https://www.csrbtx.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Cyannova Capital宣布啟動並於香港成功舉辦閉門招待會
香港, 2026年5月25日 - (亞太商訊 via SeaPRwire.com) - 總部位於紐約的投資公司Cyannova Capital ("青藍資本") 近日在其於香港島香格里拉大酒店舉行的閉門招待會上,正式推出其首支投資基金。該基金定位為「資本」與「資源整合平台」的結合體,旨在捕捉由能源、算力、自動化及太空基礎設施融合所引發的新一輪全球大投資週期浪潮。透過構建橫跨北美、中東及亞洲的全球網絡,青藍資本致力於為企業提供長期支持,重點聚焦高科技和新質生產力領域的機會,包括人工智能、可再生能源、機器人技術以及新興的太空經濟。在本次活動中,青藍資本宣布與不同集團(6090.HK)達成戰略合作框架協議。"青藍資本的核心價值遠不止於資金部署。"不同集團董事会主席汪先生表示:"不同非常榮幸能成為青藍資本的首批戰略合作夥伴之一。他們能够整合全球資源,切實幫助企業實現跨國界的規模化擴展。"本次招待會匯聚了超過200位商業領袖及戰略合作夥伴,青藍資本正式對外闡述了這一遠景。招待會期間舉辦了圍繞「數據中心融資」與「太空數據系統未來發展」的爐邊對話,展現了青藍資本對前沿技術領域的深厚承諾。此外,活動現場還舉行了與兩家重要合作夥伴的簽約儀式,進一步鞏固了公司在國際市場促進實質性跨界合作的戰略佈局。"本次招待會是我們在香港乃至整個亞洲市場建立品牌信譽的重要里程碑。" 青藍資本董事總經理 Alessandro Bianchi 表示:"此次與會的戰略合作夥伴質量之高、締結的合作關係之深,充分印證了市場對一個專注於創新企業的跨界投資平台有著強烈需求。我對我們組建的優秀團隊、選定的投資主題以及聚焦的目標地域充滿信心。我們非常期待於 2026 年下半年的資本部署。 "媒體垂詢,請聯繫:Jaysen Laijaysen@cyannovacapital.cominfo@cyannovacapital.com**本公告不應被視為投資建議或投資邀約。**關於青藍資本:青藍資本是一家總部位於紐約的投資公司,專注於能源、計算基礎設施、機器人技術及太空經濟領域。青蓝资本管理著一支配備跨界投資策略的基金,投資範圍橫跨公開與私募市場。公司致力於與成長期至中後期企業結成戰略夥伴,透過提供資金支持與戰略洞察,協助其對接新市場、戰略合作夥伴及赋能技術,從而持續提升企業的長期投資價值。關於不同集團:不同集團(6090.HK)是一家新興的科技驅動型生活方式企業,致力於為全球消費者設計、研發和製造高端嬰童及家庭生活用品。集團主要以旗下旗艦品牌「BeBeBus」運營,在出行用品、睡眠系統、餵養必需品及兒童護理等核心家庭場景中,提供高性能且具備精緻美學設計的解決方案。憑藉其自主研發的先進材料、內部研發實力以及可持續的智能製造網絡,布同集團將實用型育兒工具轉化為高度一體化的科技體驗,為全球現代精英家庭創造原創價值並提升日常尊貴的生活標準。青藍資本與不同集團(6090.HK)達成戰略合作框架協議。Moon Inc. 首席執行官John Riggins於招待會活動上發表主題演講。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
天辰生物通過聆訊:深耕過敏與自身免疫領域 臨床療效全面領先
香港, 2026年5月22日 - (亞太商訊 via SeaPRwire.com) - 生物製藥的黃金時代已然到來,慢性疾病的治療邊界被不斷刷新。在過敏性疾病與自身免疫性疾病治療需求持續釋放的背景下,專注於該領域的天辰生物醫藥(蘇州)股份有限公司(下稱「天辰生物」或「公司」)于5月21日通过港交所聆讯,擬在主板掛牌上市,國金證券(香港)擔任獨家保薦人。作為一家成立於2020年的創新藥企,天辰生物憑藉其自主研發的兩大技術平台,構建起差異化明顯的產品管線,尤其在抗IgE抗體與補體雙功能抗體領域展現出全球競爭力,核心產品臨床進展迅速,市場潛力可期。雙產品齊頭並進,臨床療效顯著天辰生物是一家臨床階段生物製藥公司,專注於過敏性及自身免疫性疾病的生物藥發現與開發。公司已構建針對鼻科、皮膚科、呼吸科、血液科、腎臟科及其他自身免疫性疾病的綜合性生物製劑產品管線,擁有一款核心產品LP-003及一款主要產品LP-005。其中,LP-003是一款具有新型序列設計的抗IgE抗體,主要用於治療季節性過敏性鼻炎(AR)、慢性自發性蕁麻疹(CSU)、過敏性哮喘等。臨床數據顯示,與已上市的同類藥物奧馬珠單抗相比,LP-003在治療CSU方面展現出顯著療效,具有起效迅速、療效良好、作用持久且劑量更低的特点。此外,LP-003與靶點的結合親和力更強,體內作用時間更長,可帶來更佳且更持久的治療效果,從而降低注射頻率,提升患者用藥便利性。目前,LP-003針對季節性AR的III期臨床試驗已完成患者入組,公司預計於2026年第三季度或之前提交生物製品許可申請(BLA),有望成為國內首個獲批用於該適應症的抗IgE抗體藥物。此外,LP-003在CSU、過敏性哮喘、慢性鼻竇炎伴鼻息肉(CRSwNP)及食物過敏等多個適應症上的臨床試驗也在同步推進中。LP-005是一款靶向C5和C3b補體的雙功能抗體融合蛋白,用於治療陣發性睡眠性血紅蛋白尿症(PNH)、補體介導腎臟疾病及全身型重症肌無力(gMG)等。與大多數針對單一靶點的補體抑制劑藥物不同,LP-005可同時作用於補體系統的兩個靶點(C5和C3b),展現出更高且更全面的活性。II期臨床數據顯示,LP-005能有效改善PNH患者的血紅蛋白水平和乳酸脫氫酶水平,安全性良好,且在接受依庫珠單抗治療控制不佳的患者中仍觀察到持續臨床獲益,展現出解決難治性PNH患者治療需求的潛力。目前,LP-005正在中國開展多項II期臨床試驗,評估其治療PNH及補體介導腎臟疾病的療效。未來,公司還將繼續拓展其應用邊界,探索gMG、MAG-PN、ALS等更多補體相關疾病中的應用潛力。兩大技術平台築基 打造差異化創新管線天辰生物的研發能力植根於兩大自有技術平台:高親和力抗體發現平台與雙功能抗體開發平台。這些平台涵蓋生物製劑開發的所有關鍵功能,使公司能夠在早期階段識別並解決潛在的臨床及製造問題,進而聚焦於最具臨床價值、成本優勢與商業潛力的候選藥物。高親和力抗體發現平台涵蓋抗原篩選與製備、動物選擇、抗體篩選方法與策略,以及抗體表徵與評估等環節,有助於生成皮摩爾級親和力及高度可成藥的抗體。經過該平台優化後,核心產品LP-003對IgE的親和力較競品奧馬珠單抗高出860倍。雙功能抗體開發平台突破了傳統抗體構型,具備結構靈活、適用性廣、成藥性高的特點。基於該平台,公司已成功開發出主要產品LP-005,以及多款在研产品,包括針對過敏性疾病的雙功能抗體 LP-00A,針對B細胞介導自身免疫性疾病的雙功能抗體或融合蛋白LP-00C,及針對特 定組織╱器官及適應症優化的雙功能抗體或融合蛋白補體抑制劑LP-00D。在這兩大平台的協同驅動下,天辰生物正持續豐富其在過敏與自身免疫疾病領域的創新產品管線,展現出持續的研發動能與豐厚的產品儲備。市場需求旺盛,藍海空間廣闊從行業前景來看,根據弗若斯特沙利文的報告,中國過敏性疾病藥物市場規模已從2018年的38億美元增長至2024年的81億美元,預計到2030年將達229億美元,該期間複合年增長率達20.1%。其中,生物製劑的市場份額預計將從2024年的19.8%提升至2030年的54.1%。在中國,季節性AR患者群體龐大,但現有治療手段存在明顯侷限。根據弗若斯特沙利文的資料,約60%的季節性AR患者在接受第二代鼻用或口服抗組胺藥及鼻用糖皮質激素治療後,療效仍然不佳。此外,針對中重度AR患者的獲批治療方案和現有藥物的療效均較為有限,且截至2024年底,中國尚無獲批用於AR的生物製劑療法藥物。這一巨大未被滿足的臨床需求,為LP-003提供了難得的市場機遇。作為一款新型抗IgE抗體,LP-003在II期臨床試驗中已展現出優於現有標準治療的潛力,並有望成為中國首個獲批用於季節性AR的生物製劑。與此同時,中國自身免疫性疾病藥物市場也處於快速增長期,預計到2030年將達190億美元。補體抑制劑正從罕見病向常見病領域加速滲透,市場潛力巨大。隨著適應症版圖持續擴張,潛在患者群體不斷壯大,推動補體藥物市場規模穩步攀升,釋放出更廣泛的疾病覆蓋能力與可觀的商業化前景。LP-005凭借在多個補體相關適應症上具備差異化競爭優勢,有望在這片廣闊市場中佔據一席之地。結語天辰生物正處於從臨床階段向商業化邁進的關鍵時期。憑藉差異化的產品管線、領先的臨床進度以及自主研發的技術平台,公司在過敏與自身免疫性疾病領域具備明確的成長路徑與市場機遇。隨著核心產品臨床試驗的穩步推進,天辰生物有望在中國創新藥浪潮中脫穎而出,成為過敏與自免領域的重要力量,為患者帶來更多創新治療選擇。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Six Factors to Consider When Opting for a Credit Line in Singapore
SINGAPORE, May 22, 2026 - (ACN Newswire via SeaPRwire.com) - In Singapore's fast-paced economy, managing cash flow effectively is key to maintaining sound financial health. Whether you face an unexpected bill or plan a large purchase, choosing an optimal credit line may provide the flexible funding you need.Unlike a fixed loan, a credit line allows you to withdraw funds only when necessary and pay interest only on the amount you actually use. Before you apply, consider these essential factors to ensure you use this financial tool responsibly.Evaluate the interest rate and total costThe most critical factor for any credit line is the interest rate, as it determines the total repayment amount. Credit Cards in Singapore typically charge interest rates in the range of 25-28% per annum, making them less suitable for long-term use.In contrast, a dedicated credit line often provides more competitive rates for short-term borrowing. Always ensure to check the Effective Interest Rate (EIR), which reflects the overall cost of borrowing, including interest and applicable fees, and gives you a clearer picture of the actual liable cost.Understand your repayment capacityBefore using your credit line, you must have a clear understanding of your current financial standing. This requires reviewing your bank balance, existing debt, and monthly income to see how much you can comfortably repay.A common mistake is treating a credit line as open-ended debt. Instead, you should create a structured repayment plan that fits your actual take-home pay. Matching your payments to your income helps prevent interest from compounding and keep your finances balanced.Check for flexibility and speedOne of the main reasons to opt for a credit line is the access to funds during unforeseen circumstances. Many banks in Singapore may offer fast approval and digital fund transfers, allowing customers to respond to urgent needs in a timely manner, subject to the bank's credit assessment and eligibility criteria.You may also wish to look for a credit line that offers flexible withdrawal options, such as via an ATM card or internet banking. This can support access to funds for unexpected or essential expenses when required. Having this access may help reduce delays associated with the long application process when access to funds are needed.Calculate the total cost of borrowingBeyond the interest rate, you should look at the extra fees that come with a credit line. Some accounts charge an annual fee or a processing fee when you first open the account. These small costs can add up and increase the total amount you owe the bank.A smart way to save money is to find a credit line that offers a fee waiver for the first year or offers promotional interest rates. You should also check if there are any charges for late payments or exceeding your credit limit. Knowing these numbers early helps you avoid surprises and keeps your borrowing costs as low as possible.Consider promotional periods and balance transfersMany lenders offer promotional interest rates to new customers for a fixed period. If you already carry high-interest debt, you can use a credit line or Balance Transfer to consolidate those costs.This strategy may help you control your interest outflow while you focus on clearing the principal balance. However, you must ensure you can repay the full amount before the promotional period ends to avoid higher standard rates.Review your long-term financial goalsWhile a credit line offers a short-term solution, it should not derail your long-term savings goals. Once you settle your immediate financial needs, you should focus on rebuilding your emergency reserves.Allocating a small percentage of your income to a reserve fund reduces your potential reliance on credit. A resilient financial structure allows you to navigate future expenses more effectively and support financial planning over the long run.Final thoughtsChoosing the right credit line is a major step in taking control of your financial journey. By comparing interest rates, checking for fees, and planning your repayments, you can use credit as a helpful tool rather than a burden, when manage appropriately. A well-managed credit line may help to support cash flow management for anticipated or unplanned expenses.Disclaimer: This content is published by iQuanti Singapore Pte Ltd, an external marketer engaged and compensated by UOB Ltd.Contact Information:Name: Sonakshi MurzeEmail: Sonakshi.murze@iquanti.comJob Title: ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com












